Acute myeloid leukaemia (AML) genetic mutation IVD, probe

Acute myeloid leukaemia (AML) genetic mutation IVD probes are used to identify specific genetic changes in a patient's specimen, helping to diagnose, monitor, or predict AML. These probes are designed to detect specific complementary-sequence nucleic acid molecules associated with AML, including certain gene mutations and chromosomal abnormalities.

When browsing this category, it's essential to understand that these devices are subject to regulatory oversight, and their supply and use are governed by specific rules. The regulation of these devices typically involves evaluation of their safety and performance in detecting specific genetic mutations, ensuring they provide accurate and reliable results for clinical decision-making.